<?xml version="1.0" encoding="UTF-8"?>
<p class="p">Given the anti MRSA activity, the potential clinical application of TTO might reside on the local administration of the drug (either at a fixed % 
 <italic class="italic">v</italic>/
 <italic class="italic">v</italic> or vehiculated by the use of nanoparticles) for the treatment of skin and soft tissue infections, including those occurring after surgery [
 <xref rid="B35-molecules-23-02584" ref-type="bibr" class="xref">35</xref>,
 <xref rid="B45-molecules-23-02584" ref-type="bibr" class="xref">45</xref>] or nasal decolonization in the case of resistance to mupirocin or other treatments [
 <xref rid="B46-molecules-23-02584" ref-type="bibr" class="xref">46</xref>].
</p>
